8 Jun
2020

AI has finally arrived, and change is coming to life sciences

Developments in AI are set to have profound implications for the life sciences sector, especially in drug discovery. IP professionals will need to adapt their strategies as AI invents, data grows in significance and new types of partnership emerge

Gareth Jones

Vice president of intellectual property

BenevolentAI